Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04183400 · ClinicalTrials.gov registry record · NA
Safety Awareness For Empowerment (SAFE): An RCT With Young People Experiencing Homelessness
A NA study, sponsored by University of Denver.
- Completed
- Registry status
- NA
- Development phase
- 244
- Enrollment target
NCT04183400: Completed NA study, sponsored by University of Denver.
NCT04183400 is a NA study that has completed, run by University of Denver. The registered enrollment target is 244 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04183400, a NA study, has completed, sponsored by University of Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 244 participants
- Enrollment target
Study Summary
The SAFE study examines the effects of brief mindfulness-based cognitive-behavioral intervention aimed at improving risk-related attention skills (risk detection, problem solving, assertiveness, and help seeking) in order to reduce substance use and victimization among young people (ages 18-21) experiencing homelessness.
Primary Outcome
The Substance use domain of the Addiction Severity Index, 5th edition will be used to assess the frequency, type and amount of substance use in the past 30 days. This domain will be adapted to add smoking tobacco to the list of substances.
Interventions
- BEHAVIORAL Safety Awareness For Empowerment (SAFE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2015-09 |
| Est. Completion | 2020-09 |
| Phase | NA |
What the finished NCT04183400 record still lists
NCT04183400 is an interventional study that assigns participants to a tested intervention. The registered 244 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Safety Awareness For Empowerment (SAFE) is the first listed.
NCT04183400 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04183400 about?
NCT04183400 is a clinical study titled "Safety Awareness For Empowerment (SAFE): An RCT With Young People Experiencing Homelessness". The SAFE study examines the effects of brief mindfulness-based cognitive-behavioral intervention aimed at improving risk-related attention skills (risk detection, problem solving, assertiveness, and help seeking) in order to reduce substance use and victimization among young people (ages 18-21) expe...
What is the current status of trial NCT04183400?
This trial is currently completed. It is a NA study. The enrollment target is 244 participants. The study started on 2015-09. Estimated completion is 2020-09.
What interventions are being tested in trial NCT04183400?
The interventions under investigation include: Safety Awareness For Empowerment (SAFE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04183400?
This trial is sponsored by University of Denver, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04183400's enrollment target sits among peer trials
244 438th of 2000 higher than 1,563 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02227251 · 244 participants · Phase 2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- NCT04317534 · 244 participants · Phase 2
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
- NCT04683250 · 244 participants · Phase 1
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
- NCT04686305 · 244 participants · Phase 1
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia